A haplotype of the phosphodiesterase 4D (PDE4D) gene is associated with myocardial infarction and with cardiometabolic parameters: the GEA study

Authors

  • José Manuel Rodríguez-Pérez Department of Molecular Biology, Instituto Nacional de Cardiología "Ignacio Chávez", Mexico City, Mexico
  • Rosalinda Posadas-Sánchez Department of Endocrinology, Instituto Nacional de Cardiología "Ignacio Chávez", Mexico City, Mexico
  • Ruben Blachman-Braun Department of Molecular Biology, Instituto Nacional de Cardiología "Ignacio Chávez", Mexico City, Mexico
  • Gilberto Vargas-Alarcón Department of Molecular Biology, Instituto Nacional de Cardiología "Ignacio Chávez", Mexico City, Mexico
  • Carlos Posadas-Romero Department of Endocrinology, Instituto Nacional de Cardiología "Ignacio Chávez", Mexico City, Mexico
  • Esbeidy García-Flores Department of Molecular Biology, Instituto Nacional de Cardiología "Ignacio Chávez", Mexico City, Mexico
  • Fabiola López-Bautista Department of Endocrinology, Instituto Nacional de Cardiología "Ignacio Chávez", Mexico City, Mexico
  • Carlos Alfonso Tovilla-Zárate Multidisciplinary Academic Division of Comalcalco, Universidad Juárez Autónoma de Tabasco, Comalcalco, Tabasco, Mexico
  • Thelma Beatriz González-Castro Multidisciplinary Academic Division of Jalpa de Méndez, Universidad Juárez Autónoma de Tabasco, Jalpa de Méndez, Mexico
  • Verónica Marusa Borgonio-Cuadra Department of Genetics, Instituto Nacional de Rehabilitación "Luis Guillermo Ibarra Ibarra", Mexico City, Mexico
  • Nonanzit Pérez-Hernández Department of Molecular Biology, Instituto Nacional de Cardiología "Ignacio Chávez", Mexico City, Mexico

DOI:

https://doi.org/10.17179/excli2018-1608

Keywords:

phosphodiesterase, myocardial infarction, polymorphisms, Mexican population

Abstract

The phosphodiesterase family is involved in a wide spectrum of diseases, including ischemic stroke. However, few studies have analyzed the relationship between phosphodiesterase 4D (PDE4D) and myocardial infarction (MI). Therefore, the aim of this research was to evaluate the association of the PDE4D gene polymorphisms with MI, and with cardiometabolic parameters in the Mexican population. Six polymorphisms (rs2910829, rs1423246, rs966221, rs4502776, rs13172481, and rs6869495) were genotyped in 1023 MI patients and 1105 healthy controls. A similar distribution of the six polymorphisms was observed in both studied groups. However, after evaluating the linkage disequilibrium, we detected a risk haplotype for MI (AGAGAA; OR = 1.148; P = 0.025). In addition, the polymorphisms were associated with the presence of some clinical and metabolic parameters (central obesity, hypertriglyceridemia, Aspartate transaminase >p75, Lipoprotein (a) >30 mg/dL, TAT >p75, fatty liver, and vitamin D <30 ng/dL) in healthy controls. The results suggest that in the Mexican population, a PDE4D haplotype is associated with increased risk of developing MI, and that PDE4D polymorphisms are independently associated with the presence of cardiometabolic parameters.

Published

2018-12-19

How to Cite

Rodríguez-Pérez, J. M., Posadas-Sánchez, R., Blachman-Braun, R., Vargas-Alarcón, G., Posadas-Romero, C., García-Flores, E., … Pérez-Hernández, N. (2018). A haplotype of the phosphodiesterase 4D (PDE4D) gene is associated with myocardial infarction and with cardiometabolic parameters: the GEA study. EXCLI Journal, 17, 1182–1190. https://doi.org/10.17179/excli2018-1608

Issue

Section

Original articles

Most read articles by the same author(s)